Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650–2666
Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516–537
Paik JM, Golabi P, Younossi Y, Saleh N, Nhyira A, Younossi ZM. The growing burden of disability related to chronic liver disease in the united states: data from the global burden of disease study 2007–2017. Hepatol Commun. 2021;5(5):749–759
Article PubMed PubMed Central Google Scholar
Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359–1376
Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res. 2021;51(7):725–749
Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353–390
Thanapirom K, Teerasarntipan T, Treeprasertsuk S, et al. Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure. Hepatol Int. 2022;16(1):171–182
Hu XH, Chen L, Wu H, et al. Cell therapy in end-stage liver disease: replace and remodel. Stem Cell Res Ther. 2023;14(1):141
Article PubMed PubMed Central Google Scholar
Zhang Z, Wang FS. Stem cell therapies for liver failure and cirrhosis. J Hepatol. 2013;59(1):183–185
Li L, Liu Y, Wang K, et al. Stem cell exosomes: new hope and future potential for relieving liver fibrosis. Clin Mol Hepatol. 2024;31:333
Article PubMed PubMed Central Google Scholar
Zhang L, Deng Y, Bai X, et al. Cell therapy for end-stage liver disease: current state and clinical challenge. Chin Med J (Engl). 2024. https://doi.org/10.1097/CM9.0000000000003332
Article PubMed PubMed Central Google Scholar
Simonson OE, Mougiakakos D, Heldring N, et al. In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome. Stem Cells Transl Med. 2016;5(6):845
Ji ST, Kim H, Yun J, Chung JS, Kwon SM. Promising therapeutic strategies for mesenchymal stem cell-based cardiovascular regeneration: from cell priming to tissue engineering. Stem Cells Int. 2017;2017:3945403
Article PubMed PubMed Central Google Scholar
Matthay MA, Pati S, Lee JW. Concise review: mesenchymal stem (stromal) cells: biology and preclinical evidence for therapeutic potential for organ dysfunction following trauma or sepsis. Stem Cells. 2017;35(2):316–324
Kuo TK, Hung SP, Chuang CH, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008;134(7):2111–2121
Haldar D, Henderson NC, Hirschfield G, Newsome PN. Mesenchymal stromal cells and liver fibrosis: a complicated relationship. Faseb J. 2016;30(12):3905–3928
Article CAS PubMed Google Scholar
Lee KD, Kuo TK, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology. 2004;40(6):1275–1284
Article CAS PubMed Google Scholar
Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292(5819):154–6. https://doi.org/10.1038/292154a0.
Article CAS PubMed Google Scholar
Yang X, Li Q, Liu W, et al. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment. Cell Mol Immunol. 2023;20(6):583–599
Article CAS PubMed PubMed Central Google Scholar
Zhang ZW. Stem cell therapies for liver failures and cirrhosis. J Hepatol. 2013;59(1):183–185
Lin H, Xu R, Zhang Z, Chen L, Shi M, Wang FS. Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases. Cell Mol Immunol. 2011;8(1):19–22
Article CAS PubMed Google Scholar
Li TT, Wang ZR, Yao WQ, Linghu EQ, Wang FS, Shi L. Stem cell therapies for chronic liver diseases: progress and challenges. Stem Cells Transl Med. 2022;11(9):900–911
Article CAS PubMed PubMed Central Google Scholar
Becker AJ, Mc CE, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature. 1963;197:452–454
Article CAS PubMed Google Scholar
Campbell KH, McWhir J, Ritchie WA, Wilmut I. Implications of cloning. Nature. 1996;380(6573):383
Article CAS PubMed Google Scholar
Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–1147
Article CAS PubMed Google Scholar
Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med. 2007;10(4):459–466
Zhou T, Yuan Z, Weng J, et al. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021;14(1):24
Article CAS PubMed PubMed Central Google Scholar
Wang L, Zhang Z, Xu R, et al. Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial. Signal Transduct Target Ther. 2021;6(1):217
Article CAS PubMed PubMed Central Google Scholar
Shi L, Wang L, Xu R, et al. Mesenchymal stem cell therapy for severe COVID-19. Signal Transduct Target Ther. 2021;6(1):339
Article CAS PubMed PubMed Central Google Scholar
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–676
Article CAS PubMed Google Scholar
Han YGC, Shi YQ. Expert consensus on standardized treatment of decompensated liver cirrhosis with stem cell transplantation (2021). J Clin Hepatol. 2021;37(07):5
Li P, Ou Q, Shi S, Shao C. Immunomodulatory properties of mesenchymal stem cells/dental stem cells and their therapeutic applications. Cell Mol Immunol. 2023;20(6):558–569
Article CAS PubMed PubMed Central Google Scholar
He Y, Guo X, Lan T, et al. Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling. Stem Cell Res Ther. 2021;12(1):396
Comments (0)